Your browser doesn't support javascript.
loading
The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue.
Beechinor, Ryan J; Mohyuddin, Ghulam Rehman; Mitchell, David E; Aaron, Daniel; Mahmoudjafari, Zahra.
Afiliação
  • Beechinor RJ; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA; UCSF School of Pharmacy, San Francisco, CA, USA. Electronic address: rbeechinor@ucdavis.edu.
  • Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Mitchell DE; Cancer Patient, President and Founder, Patient for Affordable Drugs, 1120 20th Street NW, Washington, D.C., USA.
  • Aaron D; S.J. Quinney College of Law, University of Utah, Salt Lake City, USA.
  • Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA; University of Kansas Medical Center, Westwood, KS, USA.
J Cancer Policy ; 38: 100446, 2023 12.
Article em En | MEDLINE | ID: mdl-37777010
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Genéricos / Medicare Part D Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Genéricos / Medicare Part D Idioma: En Ano de publicação: 2023 Tipo de documento: Article